Constructive Bio
Constructive Bio is a synthetic genome editing platform for biopharmaceuticals industry founded in 2021 by Jason Chin.
1
Funding Rounds
$58.0m
Money raised
Overview
Constructive Bio is a synthetic genome editing platform for biopharmaceuticals industry founded in 2021 by Jason Chin.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ch** |
|
- | - |
Funding series
Funding Series Analysis
The company Constructive Bio has raised a total of $58m in funding over 1 rounds.
Key Insights:
- Constructive Bio Series A Round, September 2024: $58m
Constructive Bio Series A Round, September 2024
$58m
Industries
Constructive Bio is active in the following industries: